Psoriasis, cardiovascular events, cancer risk and alcohol use: Evidence-based recommendations based on systematic review and expert opinion

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue SUPPL.3, 2013, Pages 2-11

  Richard, M A ^a   Barnetche, T ^b   Horreau, C ^a   Brenaut, E ^c   Pouplard, C ^d   Aractingi, S ^e   Aubin, F ^f   Cribier, B ^g   Joly, P ^h   Jullien, D ⁱ   Le Maitre M ^j   Misery, L ^c   Ortonne, J P ^k   Paul, C ^d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Methodomics SARL   (France)

^c BREST UNIVERSITY HOSPITAL   (France)

^d University of Toulouse III   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY HOSPITAL OF BESANÇON   (France)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h UNIVERSITÉ DE ROUEN   (France)

ⁱ UNIVERSITÉ DE LYON   (France)

^j Dermatologist   (France)

^k UNIVERSITÉ CÔTE D'AZUR   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYCLOSPORIN A; ETRETIN; ETRETINATE; FOLIC ACID; METHOTREXATE; METHOXSALEN;

ALCOHOL CONSUMPTION; BASAL CELL CARCINOMA; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL PRACTICE; COCHRANE LIBRARY; COMORBIDITY; CORONARY ARTERY DISEASE; DELPHI STUDY; DERMATOLOGIST; EMBASE; FOLLOW UP; HEART INFARCTION; HODGKIN DISEASE; HUMAN; MEDLINE; MELANOMA; META ANALYSIS; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; PSORIASIS; PUVA; RATING SCALE; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN LYMPHOMA; SMOKING; SOLID; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

ALCOHOLISM; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PSORIASIS; QUESTIONNAIRES; REVIEW LITERATURE AS TOPIC; RISK;

EID: 84880266973     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12162     Document Type: Review

References (42)

1. Paul C, Gourraud PA, Bronsard V, et al,. Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol 2010; 24 (Suppl. 2): 2-9.
2. Prey S, Paul C, Bronsard V, et al,. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 2010; 24 (Suppl. 2): 23-30.
3. Prey S, Paul C, Bronsard V, et al,. Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol 2010; 24 (Suppl. 2): 31-35.
4. Horreau C, Pouplard C, Brenaut E, et al,. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 2013; 27 (Suppl. 3): 12-29.
5. Brenaut E, Horreau C, Pouplard C, et al,. Alcohol consumption and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2013; 27 (Suppl 3): 30-35.
6. Pouplard C, Brenaut E, Horreau C, et al,. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol 2013; 27 (Suppl. 3): 36-46.
7. Paul C, Gallini A, Maza A, et al,. Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol 2011; 25 (Suppl. 2): 2-11.
8. Paul C, Gallini A, Archier E, et al,. Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol 2012; 26 (Suppl. 2): 1-10.
9. van Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003; 28: 1290-1299. (Pubitemid 36734620)
10. Roddy E, Zhang W, Doherty M, et al,. Evidence-based clinical guidelines: a new system to better determine true strength of recommendation. J Eval Clin Pract 2006; 12: 347-352. (Pubitemid 43806715)
11. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB,. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741. (Pubitemid 44547793)
12. Brauchli YB, Jick SS, Miret M, Meier CR,. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 2009; 160: 1048-1056.
13. Xiao J, Chen LH, Tu YT, Deng XH, Tao J,. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 2009; 23: 1311-1315.
14. Ahlehoff O, Gislason GH, Charlot M, et al,. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011; 270: 147-157.
15. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M,. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-328.
16. Kimball AB, Robinson D Jr, Wu Y, et al,. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 2008; 217: 27-37. (Pubitemid 351896565)
17. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M,. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010; 37: 146-155.
18. Gelfand JM, Dommasch ED, Shin DB, et al,. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009; 129: 2411-2418.
19. Jankovic S, Raznatovic M, Marinkovic J, Jankovic J, Maksimovic N,. Risk factors for psoriasis: A case-control study. J Dermatol 2009; 36: 328-334.
20. Poikolainen K, Reunala T, Karvonen J, Lauharanta J, Kärkkäinen P,. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ 1990; 300: 780-783. (Pubitemid 20109272)
21. Qureshi AA, Dominguez PL, Choi HK, Han J, Curhan G,. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol 2010; 146: 1364-1369.
22. Wolk K, Mallbris L, Larsson P, Rosenblad A, Vingård E, Ståhle M,. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol 2009; 89: 492-497.
23. Gupta MA, Schork NJ, Gupta AK, Ellis CN,. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28 (5 Pt 1): 730-732. (Pubitemid 23133383)
24. Carmichael MM, Stankler L, White MI,. Alcohol intake of patients with psoriasis and dermatitis. Health Bull (Edinb) 1984; 42: 258-262.
25. Vincenti GE, Blunden SM,. Psoriasis and alcohol abuse. J R Army Med Corps 1987; 133: 77-78.
26. Stern RS, Lange R,. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988; 91: 197-201.
27. Lindelöf B, Eklund G, Lidén S, Stern RS,. The prevalence of malignant tumors in patients with psoriasis. J Am Acad Dermatol 1990; 22: 1056-1060. (Pubitemid 20186129)
28. Margolis D, Bilker W, Hennessy S, Vittorio C, Santanna J, Strom BL,. The risk of malignancy associated with psoriasis. Arch Dermatol 2001; 137: 778-783. (Pubitemid 32577862)
29. Brauchli YB, Jick SS, Miret M, Meier CR,. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 2009; 129: 2604-2612.
30. Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB,. The risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006; 126: 2194-2201. (Pubitemid 44413165)
31. Hannuksela-Svahn A, Pukkala E, Läärä E, Poikolainen K, Karvonen J,. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 2000; 114: 587-590. (Pubitemid 30415349)
32. Ji J, Shu X, Sundquist K, Sundquist J, Hemminki K,. Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden. Br J Cancer 2009; 100: 1499-1502.
33. Hannuksela-Svahn A, Pukkala E, Koulu L, Jans\xE9n CT, Karvonen J,. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. J Am Acad Dermatol 1999; 40: 694-696. (Pubitemid 29230354)
34. Frentz G, Olsen JH,. Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 1999; 140: 237-242. (Pubitemid 29111349)
35. Nast A, Kopp I, Augustin M, et al,. German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version). Arch Dermatol Res 2007; 299: 111-138. (Pubitemid 46835379)
36. Pathirana D, Ormerod AD, Saiag P, et al,. European S3-Guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23: 5-70.
37. Puig L, Bordas X, Carrascosa JM, et al,. [Consensus Document on the Evaluation and Treatment of Moderate to Severe Psoriasis. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology]. Actas Dermosifiliogr 2009; 100: 277-286.
38. Smith CH, Anstey AV, Barker JNWN, et al,. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009; 161: 987-1019.
39. Archier E, Devaux S, Castela E, et al,. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26 (Suppl. 3): 22-31.
40. Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM,. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 2010; 163: 586-592.
41. Gulliver WP, Macdonald D, Gladney N, Alaghehbandan R, Rahman P, Adam Baker K,. Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population. J Cutan Med Surg 2011; 15: 37-47.
42. Shu X, Ji J, Sundquist J, Sundquist K, Hemminki K,. Survival in cancer patients hospitalized for psoriasis: a population-based cohort study in Sweden. Br J Dermatol 2011; 165: 129-136.